Device programming

DEVICE4 trials

Sponsors

Montreal Heart Institute, Aston University, Medical University Innsbruck, Medical University of Lodz

Conditions

BradyarrhythmiaCardiac FailureHeart Failure

Phase 3

CRT Improved Clinical Response UK Trial

WithdrawnNCT02669134

Aston UniversityCardiac Failure

Start: 2016-03-31End: 2018-09-30Updated: 2023-08-02

Phase 4

Evaluation of Resynchronization Therapy for Heart Failure (EARTH)

CompletedNCT00901212

Montreal Heart InstituteHeart Failure

Start: 2003-10-31End: 2010-02-28Target: 120Updated: 2012-05-08

Unknown Phase

Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology

RecruitingNCT04662970

Medical University InnsbruckHeart Failure

Start: 2020-01-01End: 2027-12-31Target: 25Updated: 2025-10-02

Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing

Medical University of LodzBradyarrhythmia

Start: 2020-12-14End: 2022-12-31Target: 100Updated: 2022-11-03

Related Papers

Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds.

2011-11-2199 citations

Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics.

2011-07-2416 citations